Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Artificial Organs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The global artificial organs market size reached US$ 17.4 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 29.2 Billion by 2027, exhibiting at a CAGR of 8.8% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Artificial organs are engineered devices implanted in a human body to replicate the functions of a healthy organ or perform a specific function. They are composed of plastic seeded with stem cells from the transplant recipient. Due to this, the immune system of the body does not reject the artificial organ. They do not require continuous tethering to a power supply or any other stationary resource to keep patients with serious organ failure alive for years.

 

 
 

www.imarcgroup.com

Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

The global artificial organs market is primarily driven by the increasing number of people suffering from organ failures, especially the aging population, due to severe health conditions, such as diabetes, heart disorders, and chronic kidney diseases. The frequent occurrence of road accidents and injuries leading to amputations have also increased the demand for artificial organs. Besides this, the growing public awareness about advancements in medical technology and improvements in the existing healthcare infrastructure hasled to the development of advanced artificial support systems. Moreover, the introduction of 3D bioprinting and the integration of artificial intelligence (AI) in the production of artificial devices are providing a positive outlook to the market. On the other hand, the high implantation cost and limited surgical expertise in most regions are expected to restrain the market growth. However, the unavailability and shortage of organ donors at the time of requirement have encouraged the development of artificial organ technology across the globe.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global artificial organs market, along with forecasts at the global and regional level from 2022-2027. Our report has categorized the market based on type.

Breakup by Type:

 

 
 

www.imarcgroup.com

Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

  • Artificial Kidney
  • Artificial Heart
  • Artificial Pancreas
  • Cochlear Implants
  • Others
     

Amongst these, artificial kidneys represent the largest product type.

Regional Insights:

 

 
 

www.imarcgroup.com

To get more information on the regional analysis of this market, Request Sample

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
     

On a regional basis, North America exhibits a clear dominance in the market.

Competitive Landscape:

The competitive landscape of the market has also been analyzed, with some of the key players being Abiomed Inc., Edwards Lifesciences Corp, HeartWare International, Inc., Cochlear Limited, and Boston Scientific Corporation.

This report provides a deep insight into the global artificial organs market, covering all its essential aspects. This ranges from macro-overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the artificial organs industry in any manner.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Billion
Segment Coverage Type, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Companies Covered Abiomed Inc., Edwards Lifesciences Corp, HeartWare International, Inc., Cochlear Limited, and Boston Scientific Corporation
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Artificial Organs Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Breakup by Type
    5.5    Market Breakup by Region
    5.6    Market Forecast
    5.7    SWOT Analysis
        5.7.1    Overview
        5.7.2    Strengths
        5.7.3    Weaknesses
        5.7.4    Opportunities
        5.7.5    Threats
    5.8    Value Chain Analysis
        5.8.1    Overview
        5.8.2    Research and Development
        5.8.3    Raw Material Procurement
        5.8.4    Manufacturing
        5.8.5    Marketing
        5.8.6    Distribution
        5.8.7    End-Use
    5.9    Porters Five Forces Analysis
        5.9.1    Overview
        5.9.2    Bargaining Power of Buyers
        5.9.3    Bargaining Power of Suppliers
        5.9.4    Degree of Competition
        5.9.5    Threat of New Entrants
        5.9.6    Threat of Substitutes
6   Market Breakup by Type
    6.1    Artificial Kidney
        6.1.1    Market Trends
        6.1.2    Market Forecast
    6.2    Artificial Heart
        6.2.1    Market Trends
        6.2.2    Market Forecast
    6.3    Artificial Pancreas
        6.3.1    Market Trends
        6.3.2    Market Forecast
    6.4    Cochlear Implants
        6.4.1    Market Trends
        6.4.2    Market Forecast
    6.5    Others
        6.5.1    Market Trends
        6.5.2    Market Forecast
7   Market Breakup by Region
    7.1    North America
        7.1.1    Market Trends
        7.1.2    Market Forecast
    7.2    Europe
        7.2.1    Market Trends
        7.2.2    Market Forecast
    7.3    Asia Pacific
        7.3.1    Market Trends
        7.3.2    Market Forecast
    7.4    Middle East and Africa
        7.4.1    Market Trends
        7.4.2    Market Forecast
    7.5    Latin America
        7.5.1    Market Trends
        7.5.2    Market Forecast
8   Competitive Landscape
    8.1    Market Structure
    8.2    Key Players
    8.3    Profiles of Key Players
        8.3.1    Abiomed, Inc.
            8.3.1.1    Company Overview
            8.3.1.2    Description
            8.3.1.3    Product Portfolio
            8.3.1.4    Financials
            8.3.1.5    SWOT Analysis
        8.3.2    HeartWare International, Inc.
            8.3.2.1    Company Overview
            8.3.2.2    Description
            8.3.2.3    Product Portfolio
            8.3.2.4    Financials
            8.3.2.5    SWOT Analysis
        8.3.3    Edwards Lifesciences Corp
            8.3.3.1    Company Overview
            8.3.3.2    Description
            8.3.3.3    Product Portfolio
            8.3.3.4    Financials
            8.3.3.5    SWOT Analysis
        8.3.4    Boston Scientific Corporation
            8.3.4.1    Company Overview
            8.3.4.2    Description
            8.3.4.3    Product Portfolio
            8.3.4.4    Financials
            8.3.4.5    SWOT Analysis
        8.3.5    Cochlear Limited
            8.3.5.1    Company Overview
            8.3.5.2    Description
            8.3.5.3    Product Portfolio
            8.3.5.4    Financials
            8.3.5.5    SWOT Analysis

List of Figures

Figure 1: Global: Artificial Organs Market: Major Drivers and Challenges
Figure 2: Global: Artificial Organs Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Artificial Organs Market: Breakup by Type (in %), 2021
Figure 4: Global: Artificial Organs Market: Breakup by Region (in %), 2021
Figure 5: Global: Artificial Organs Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 6: Global: Artificial Organs Industry: SWOT Analysis
Figure 7: Global: Artificial Organs Industry: Value Chain Analysis
Figure 8: Global: Artificial Organs Industry: Porter’s Five Forces Analysis
Figure 9: Global: Artificial Organs (Artificial Kidney) Market: Sales Value (in Million US$), 2016 & 2021
Figure 10: Global: Artificial Organs (Artificial Kidney) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 11: Global: Artificial Organs (Artificial Heart) Market: Sales Value (in Million US$), 2016 & 2021
Figure 12: Global: Artificial Organs (Artificial Heart) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 13: Global: Artificial Organs (Artificial Pancreas) Market: Sales Value (in Million US$), 2016 & 2021
Figure 14: Global: Artificial Organs (Artificial Pancreas) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 15: Global: Artificial Organs (Cochlear Implants) Market: Sales Value (in Million US$), 2016 & 2021
Figure 16: Global: Artificial Organs (Cochlear Implants) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 17: Global: Artificial Organs (Other Types) Market: Sales Value (in Million US$), 2016 & 2021
Figure 18: Global: Artificial Organs (Other Types) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 19: North America: Artificial Organs Market: Sales Value (in Million US$), 2016 & 2021
Figure 20: North America: Artificial Organs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 21: Europe: Artificial Organs Market: Sales Value (in Million US$), 2016 & 2021
Figure 22: Europe: Artificial Organs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 23: Asia Pacific: Artificial Organs Market: Sales Value (in Million US$), 2016 & 2021
Figure 24: Asia Pacific: Artificial Organs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 25: Middle East and Africa: Artificial Organs Market: Sales Value (in Million US$), 2016 & 2021
Figure 26: Middle East and Africa: Artificial Organs Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 27: Latin America: Artificial Organs Market: Sales Value (in Million US$), 2016 & 2021
Figure 28: Latin America: Artificial Organs Market Forecast: Sales Value (in Million US$), 2022-2027

List of Tables

Table 1: Global: Artificial Organs Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Artificial Organs Market Forecast: Breakup by Type (in Million US$), 2022-2027
Table 3: Global: Artificial Organs Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 4: Global: Artificial Organs Market Structure
Table 5: Global: Artificial Organs Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Key Questions Answered in This Report

The global artificial organs market was valued at US$ 17.4 Billion in 2021.

We expect the global artificial organs market to exhibit a CAGR of 8.8% during 2022-2027.

The increasing instances of organ failures, along with continuous improvements in the existing
healthcare infrastructures, are currently driving the global artificial organs market.

The sudden outbreak of COVID-19 pandemic had led to implementation of stringent lockdown
regulations across several nations resulting in the postponement of elective surgeries to combat the
risk of the coronavirus infection.

Based on the type, the global artificial organs market can be bifurcated into artificial kidney, artificial
heart, artificial pancreas, cochlear implants, and others. Among these, artificial kidneys account for
the largest market share.

On a regional level, the market has been classified into North America, Asia Pacific, Europe, Latin
America, and Middle East and Africa, where North America currently dominates the global market.

Some of the major players in the global artificial organs market include Abiomed Inc., Edwards
Lifesciences Corp, HeartWare International, Inc., Cochlear Limited, and Boston Scientific
Corporation.

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links